Beyond its direct cellular functions, CD81 also modulates the immune environment with tumour hosts to mediately involve cancer progression, such as impairing the suppressive ability of T regulatory cells (Tregs) and myeloid‐derived suppressor cells (MDSCs) in tumour‐bearing mice [23]. This evidence concerns the gene CD81 and cancer.